Patents by Inventor Matthias Vennemann

Matthias Vennemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090246169
    Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5 and R6 have the meanings indicated in the description, are effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: February 21, 2007
    Publication date: October 1, 2009
    Inventors: Matthias Vennemann, Thomas Bar, Jürgen Braunger, Astrid Zimmermann, Volker Gekeler
  • Publication number: 20090233902
    Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5 and R6 have the meanings indicated in the description, are effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: February 21, 2007
    Publication date: September 17, 2009
    Inventors: Matthias Vennemann, Thomas Bãr, Jürgen Braunger, Astrid Zimmermann, Volker Gekeler
  • Publication number: 20090137607
    Abstract: Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.
    Type: Application
    Filed: August 14, 2008
    Publication date: May 28, 2009
    Inventors: Swen Holder, Matthias Vennemann, Gerrit Beneke, Armin Zulch, Volker Gekeler, Thomas Beckers, Astrid Zimmermann, Hemant Joshi
  • Publication number: 20080161338
    Abstract: The invention relates to novel pyrrolodihydroisoquinoline derivatives, which are efficacious inhibitors of PDE10.
    Type: Application
    Filed: January 11, 2006
    Publication date: July 3, 2008
    Applicant: ALTANA PHARMA AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Paola Ciapetti, Jean-Marie Contreras, Camille George Wermuth
  • Publication number: 20080125452
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5 and X have the meanings indicated in the description, are novel effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: January 26, 2006
    Publication date: May 29, 2008
    Applicant: ALTANA PHARMA AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Petra Gimmnich, Thomas Beckers, Mathias Schmidt, Thomas Ciossek, Sandra Nappe
  • Publication number: 20080114017
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5, R6 and X have the meanings indicated in the description, are novel effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: January 26, 2006
    Publication date: May 15, 2008
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Petra Gimmnich
  • Publication number: 20080064714
    Abstract: The invention relates to novel pyrrolodihydroisoquinoline derivatives which are efficacious inhibitors of cellular (hyper)proliferation and/or inducers of apoptosis in cancer cells.
    Type: Application
    Filed: January 11, 2006
    Publication date: March 13, 2008
    Applicant: NYCOMED GMBH
    Inventors: Matthias Vennemann, Thomas Bar, Juergen Braunger, Volker Gekeler, Petra Gimmnich, Paola Ciapetti, Jean-Marie Contreras, Camille Wermuth
  • Publication number: 20070232596
    Abstract: Compounds of the formula (1) in which R1, R2, R3, R4 and X have the meanings indicated in the description, are novel effective compounds with Eg5 inhibitory, anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: August 17, 2005
    Publication date: October 4, 2007
    Applicant: Altana Pharma AG
    Inventors: Matthias Vennemann, Thomas Baer, Gudrun Groegor, Jurgen Braunger, Petra Gimmnich, Thomas Maier, Heike Rothfels
  • Publication number: 20070184979
    Abstract: Compounds of the formula I in which the substitutents have the definitions provided in the specification, are novel, effective HDAC inhibitors.
    Type: Application
    Filed: March 10, 2005
    Publication date: August 9, 2007
    Applicant: ALTANA PHARMA AG
    Inventors: Thomas Maier, Thomas Beckers, Thomas Baer, Petra Gimmnich, Frank Dullweber, Matthias Vennemann
  • Publication number: 20070105840
    Abstract: The invention relates to the use of a pyrrolo ‘2,1-a’ isoquinoline structure-element as an integral part of the overall structure of compounds which inhibit PDE10.
    Type: Application
    Filed: June 30, 2004
    Publication date: May 10, 2007
    Applicant: Altana Pharma AG
    Inventors: Thomas Bar, Matthias Vennemann
  • Publication number: 20060148840
    Abstract: The invention relates to novel pyrrolodihydroisoquinoline derivatives, which are efficacious inhibitors of PDE10.
    Type: Application
    Filed: June 30, 2004
    Publication date: July 6, 2006
    Applicant: Altana Pharma AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger
  • Publication number: 20060148838
    Abstract: The invention relates to novel pyrrolodihydroisoquinoline derivatives, which are efficacious inhibitors of cellular (hyper)proliferation and/or inducers of apoptosis in cancer cells.
    Type: Application
    Filed: June 30, 2004
    Publication date: July 6, 2006
    Applicant: Altana Pharma AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Volker Gekeler